Tell us about your product, market, and timeline — our specialists will design a testing programme that fits.
Our scientific team will help you identify the right tests, methods, and accreditations for your product or sample.
CDSCO Approved Laboratory
NABL-accredited labs with CDSCO approvals for pharmaceutical testing, medical device testing, and clinical research — Delhi, Manesar, and Bahadurgarh.
CDSCO is a regulatory approval authority — not an accreditation body like NABL. CDSCO covers several distinct approval types under the Drugs and Cosmetics Act. Each Auriga lab holds the specific approval(s) listed below, and each approval type has its own scope.
Labs: Delhi and Bahadurgarh
Approval for testing medical devices under the Medical Devices Rules 2017 — biocompatibility, packaging, sterility, and device-grade material work for CDSCO medical device registration dossiers.
Labs: Delhi, Manesar, and Baddi
Drug Licence approval under the Drugs and Cosmetics Act for testing pharmaceutical raw materials and finished products — assay, related substances, dissolution, stability, and impurity work.
Labs: Manesar — Clinical Research Division
DCGI approval for CRO activities at the Manesar (IMT Manesar, Plot 136, Sector 5) Clinical Research Division — clinical trials, BA/BE studies, and PK/PD work. Held continuously since 1995.
Labs: Manesar
CDSCO/DCGI approval for conducting clinical studies at the Manesar CRD — supporting Sugam-portal clinical trial applications since 2000.
Distinct approval types: MD-40, Form-37 Drug Licence, DCGI CRO Approval, and CDSCO clinical-study approval are four separate regulatory approvals with separate scopes. Quotes specify the approval type relevant to your dossier and the lab that holds it.
Four common dossier and registration scenarios where the testing lab must hold a specific CDSCO approval.
Stability, assay, and impurity data for a CDSCO drug registration dossier must come from a Form-37 approved laboratory. Auriga Delhi, Manesar, and Baddi hold Form-37 Drug Licence approvals.
Biocompatibility, bioburden, and packaging testing for a medical device CDSCO submission must come from an MD-40 registered lab. Auriga Delhi and Bahadurgarh hold MD-40 approval.
A clinical trial application submitted to CDSCO via the Sugam portal requires a DCGI-approved CRO. Auriga's Manesar CRD has held DCGI approval since 1995 and CDSCO clinical study approval since 2000.
CDSCO import registration applications for cosmetics require testing at a CDSCO-approved laboratory. Auriga Delhi supports cosmetic import dossier testing under the Cosmetics Rules 2020.
Every Auriga lab holding a CDSCO approval, the approval type, the scope, and the year the approval has been held. Year fields marked "Confirm year" to be confirmed with the lab team before go-live.
| Lab | Approval Type | Scope | Since |
|---|---|---|---|
| Delhi | MD-40 Medical Device | Medical device testing | Confirm year |
| Delhi | Form-37 Drug Licence | Pharma raw material and finished product | Confirm year |
| Manesar | Form-37 Drug Licence | Pharma testing | Confirm year |
| Manesar | DCGI CRO Approval | Clinical trials, BA/BE, PK/PD | 1995 |
| Manesar | CDSCO CRO Approval | Clinical studies | 2000 |
| Baddi | Form-37 Drug Licence | Pharma testing | Confirm year |
| Bahadurgarh | MD-40 Medical Device | Medical device testing | Confirm year |
CDSCO approval letters, Form-37 Drug Licences, and the DCGI CRO approval for Manesar are available for vendor qualification, due diligence, regulatory submissions, and tender requirements.
View CDSCO Approval Letters and Form-37 LicencesMD-40 medical device, Form-37 pharma, and DCGI CRO approvals across Delhi, Manesar, Baddi, and Bahadurgarh. NABL accredited. Reports formatted for CDSCO Sugam-portal and dossier submissions.
Download a practical testing guide tailored to your industry — checklists, parameters, and regulatory tips in one place.
Download Guide Request a Quote InsteadNo thanks, I'll keep browsing